Akebia Therapeutics Inc (AKBA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -61.264 | -23.151 | -21.104 | -31.64 | -54.186 | -48.362 | -21.1 | -17.497 |
Return on Equity (%) | -136.348 | -82.063 | -38.024 | -54.267 | -119.387 | -174.553 | -215.767 | 488.89 |
Return on Invested Capital (%) | -138.921 | -86.914 | -46.002 | -55.936 | -65.487 | -137.82 | -133.044 | -167.114 |
Operating Margin (%) | -8843.453 | -43.214 | -82.759 | -85.459 | -126.846 | -123.095 | -26.273 | -23.58 |
Net Profit Margin (%) | -8843.453 | -43.214 | -69.118 | -83.48 | -129.85 | -132.429 | -31.634 | -26.68 |
Book Value Per Share | 1.764 | 2.506 | 2.162 | 0.399 | 0.327 | -0.49 | -0.64 | -0.667 |
Earnings Per Share | -3.515 | -1.615 | -1.228 | -2.298 | -2.59 | -1.598 | -0.503 | -0.276 |
Cash Per Share | 4.851 | 1.473 | 0.895 | 1.212 | 1.544 | 0.846 | 0.492 | 0.228 |
Working Capital Per Share | 4.714 | 4.495 | 1.733 | 0.833 | 1.245 | 0.088 | 0.327 | 0.097 |
Operating Profit Per Share | 0.04 | 3.738 | 1.724 | 1.858 | 0.989 | 0.555 | 1.335 | 0.839 |
EBIT Per Share | -3.515 | -1.615 | -1.471 | -2.353 | -2.59 | -1.598 | -0.503 | -0.276 |
EBITDA Per Share | -3.515 | -1.615 | -1.471 | -2.353 | -2.59 | -1.598 | -0.503 | -0.276 |
Free Cash Flow Per Share | -3.454 | -1.594 | -1.235 | -2.561 | -2.815 | -1.812 | -0.707 | -0.475 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 38,62M | 47,61M | 116,89M | 121,68M | 148,07M | 177M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -61.445 | N/A | N/A | N/A | -47.496 | N/A | N/A |
Net Profit Margin (%) | N/A | -65.335 | N/A | N/A | N/A | -55.157 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 390,54M |
Ratio cours/bénéfice | -7,69 |
Ratio prix/ventes | 2,05 |
Ratio prix/liquidités | 9,3 |
Ratio prix/valeur comptable | -13,05 |
Rendement de dividende | - |
Actions en circulation | 218,18M |
Volume moyen (1 semaine) | 1,84M |
Volume moyen (1 mois) | 2,11M |
Variation sur 52 semaines | 56,65% |
Plus haut sur 52 semaines | 2,48 |
Plus bas sur 52 semaines | 0,80 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales